Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-004 - Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status
09:30 - 09:30 | Presenter: Hirotsugu Kenmotsu | Author(s): E. Iwama, Yasushi Goto, T. Harada, S. Tsumura, H. Sakashita, Y. Mori, N. Nakagaki, Y. Fujita, M. Seike, A. Bessho, M. Ono, A. Okazaki, H. Akamatsu, R. Morinaga, S. Ushijima, T. Shimose, S. Tokunaga, A. Hamada, Nobuyuki Yamamoto, Yoichi Nakanishi, K. Sugio, Isamu Okamoto
- Abstract
Loading...
-
+
P1.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P1.07-014 - Association of Preoperative Serum CRP with PD-L1 Expression in NSCLC: A Comprehensive Analysis of Systemic Inflammatory Markers
09:30 - 09:30 | Presenter: Takaki Akamine | Author(s): Kazuki Takada, Gouji Toyokawa, F. Kinoshita, T. Matsubara, Yuka Kozuma, Naoki Haratake, Shinkichi Takamori, F. Hirai, T. Tagawa, Tatsuro Okamoto, Y. Yoneshima, Isamu Okamoto, M. Shimokawa, Y. Oda, Yoichi Nakanishi, Y. Maehara
- Abstract
Loading...
-
+
P1.08 - Locally Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Locally Advanced NSCLC
-
+
P1.08-006 - Phase I/II Study of Carboplatin, nab-paclitaxel, and Concurrent Radiation Therapy for Patients with Locally Advanced NSCLC.
09:30 - 09:30 | Presenter: Yuko Kawano | Author(s): H. Yamaguchi, K. Hirano, A. Horiike, Miyako Satouchi, Shinobu Hosokawa, R. Morinaga, Kazutoshi Komiya, K. Inoue, Y. Fujita, M. Takenoyama, Tomoki Kimura, M. Okuno, Y. Hisamatsu, J. Kishimoto, T. Sasaki, Yoichi Nakanishi, Isamu Okamoto
- Abstract
Loading...
-
+
OA 05 - Next Generation TKI
- 15:45 - 17:30
- 10/16/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:James Chih-Hsin Yang, Fiona Blackhall
-
+
OA 05.02 - Osimertinib vs SoC EGFR-TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA): Plasma ctDNA Analysis
15:55 - 16:05 | Presenter: Jhanelle Elaine Gray | Author(s): Isamu Okamoto, V. Sriuranpong, Johan F. Vansteenkiste, F. Imamura, J.S. Lee, Y. Pang, M. Cobo, K. Kasahara, R. Hodge, Brian B Lentrichia, S. Dearden, Suresh S Ramalingam
- Abstract
Loading...
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-045 - Updated Results of Phase II, Liquid Biopsy Study in EGFR Mutated NSCLC Patients Treated with Afatinib (WJOG 8114LTR)
09:30 - 09:30 | Presenter: Hidetoshi Hayashi | Author(s): H. Akamatsu, Y. Koh, S. Morita, Daichi Fujimoto, Isamu Okamoto, A. Bessho, K. Azuma, Kazuhiko Nakagawa, Nobuyuki Yamamoto
- Abstract
Loading...
-
+
P2.15 - SCLC/Neuroendocrine Tumors
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: SCLC/Neuroendocrine Tumors
-
+
P2.15-004 - Underrepresentation of Elderly Patients with ED-SCLC as Clinical Trial Candidates (JCOG1201/TORG1528)
09:30 - 09:30 | Presenter: Yuki Misumi | Author(s): Tsuneo Shimokawa, Hiroaki Okamoto, Shinji Atagi, H. Tanaka, Koichi Goto, Kazuhiko Nakagawa, T. Hida, Nobuyuki Yamamoto, Y. Hosomi, Terufumi Kato, Isamu Okamoto, Yuichiro Ohe
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-075 - Afatinib Dose Adjustment: Effect on Safety, Efficacy and Patient-Reported Outcomes in the LUX-Lung 3/6 Trials in EGFRm+ NSCLC
09:30 - 09:30 | Presenter: Vera Hirsh | Author(s): E. Tan, Yi-Long Wu, Lecia V Sequist, Caicun Zhou, Martin Schuler, S.L. Geater, Tony SK Mok, C. Hu, Nobuyuki Yamamoto, J. Feng, Kenneth Obyrne, Shun Lu, Y. Huang, M. Sebastian, Isamu Okamoto, N. Dickgreber, R. Shah, M. Palmer, A. Märten, D. Massey, C. Samuelsen, James Chih-Hsin Yang
- Abstract
Loading...
-
+
P3.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P3.04-002 - A Randomized Phase II Study of Carboplatin plus Nab-Paclitaxel with or Without Nintedanib for NSCLC with IPF (J-SONIC): Trial in Progress
09:30 - 09:30 | Presenter: Kohei Otsubo | Author(s): J. Kishimoto, Hirotsugu Kenmotsu, Y. Minegishi, Eiki Ichihara, A. Shiraki, Terufumi Kato, Shinji Atagi, Hidehito Horinouchi, M. Ando, Y. Kondoh, Masahiko Kusumoto, K. Ichikado, Nobuyuki Yamamoto, Yoichi Nakanishi, Isamu Okamoto
- Abstract
Loading... -
+
P3.04-004 - Treatment Rationale and Study Design for the TAKUMI Trial
09:30 - 09:30 | Presenter: Kentaro Tanaka | Author(s): H. Asahina, J. Kishimoto, K. Sugio, Yoichi Nakanishi, S. Oizumi, Isamu Okamoto
- Abstract
Loading...
-
+
MS 25 - Novel Molecular Targets (KRAS/MET/Novel Fusions): Druggable or Not?
- 14:30 - 16:15
- 10/18/2017
- Location: Main Hall
- Type: Mini Symposium
- Track: Chemotherapy/Targeted Therapy
- Moderators:Rafael Rosell, Isamu Okamoto
-
+
MS 25.01 - Discovery of Novel Molecular Targets
14:30 - 14:50 | Presenter: Pasi A Jänne
- Abstract
No abstract available for this presentation
-
+
MS 25.02 - KRAS-Targeted Therapy or Angiogenesis: Still a Viable Target?
14:50 - 15:10 | Presenter: Ravi Salgia | Author(s): I. Mambetsariev, I. Amanam, A. Nam
- Abstract
Loading... -
+
MS 25.03 - MET-Related Molecular Targets
15:10 - 15:30 | Presenter: Alexander Drilon
- Abstract
Loading... -
+
MS 25.04 - FGFR-Related Novel Molecular Targets
15:30 - 15:50 | Presenter: Kazuto Nishio
- Abstract
Loading... -
+
MS 25.05 - Novel Fusions
15:50 - 16:10 | Presenter: Robert C. Doebele
- Abstract
Loading... -
+
MS 25.06 - Q&A
16:10 - 16:15
- Abstract
No abstract available for this presentation